Taken together, we hypothesize that leukaemogenic progression in MLL-ENL and MOZ-TIF2 AML models is associated with altered expression of HSPC-TFs which, in turn, is accompanied by corresponding changes in H3K9ac profiles at their candidate regulatory regions. This evidence concerns the gene KMT2A and acute myeloid leukemia.